---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-015059"
form_type: "8-K"
ticker: "XFOR"
cik: "0001501697"
company_name: "X4 Pharmaceuticals, Inc"
filed_at: "2024-04-05T23:59:59+00:00"
generated_at: "2026-06-04T01:47:19.453094+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# X4 Pharmaceuticals regains Nasdaq bid price compliance; deficiency notice closed

## Summary
- Received Nasdaq deficiency notice on Nov 13, 2023 for bid price below $1.00 for 30 consecutive trading days.
- On April 5, 2024, Nasdaq confirmed compliance with Bid Price Rule; matter now closed.
- Common stock (XFOR) remains listed on The Nasdaq Stock Market.

## SEC filing metadata
- accession: 0001628280-24-015059
- form_type: 8-K
- ticker: XFOR
- cik: 0001501697
- company_name: X4 Pharmaceuticals, Inc
- filed_at: 2024-04-05T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501697/000162828024015059/0001628280-24-015059-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501697/000162828024015059/xfor-20240405.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-015059
- JSON: https://secwatch.observer/filing/0001628280-24-015059.json
- Plain text: https://secwatch.observer/filing/0001628280-24-015059.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.